MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3390/cancers14184485

Медицинская библиотека · Cancers · 2022

Clinical Features, Gene Alterations, and Outcomes in Prefibrotic and Overt Primary and Secondary Myelofibrotic Patients.

Kim Tong-Yoon, Kwag Daehun, Lee Jong-Hyuk, Lee Joonyeop, Min Gi-June, Park Sung-Soo, Park Silvia, Jeon Young-Woo, Yoon Jae-Ho, Shin Seung-Hawn, Yahng Seung-Ah, Cho Byung-Sik, Eom Ki-Seong, Kim Yoo-Jin, Lee Seok, Kim Hee-Je, Min Chang-Ki, Cho Seok-Goo, Lee Jong-Wook, Lee Jong-Mi, Kim Myungshin, Lee Sung-Eun

СтатьяПеревод пока не подготовлен

Аннотация

The Philadelphia-negative myeloproliferative neoplasms (MPNs) are divided in three major groups: polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF). The 2016 WHO classification incorporates also prefibrotic PMF (pre-PMF) and overt PMF. This study aimed to discriminate the clinical features, genetic alterations, and outcomes in patients with prefibrotic, overt PMF, and secondary MF (SMF). This study included 229 patients with diagnosed myelofibrosis (MF). Among 229 patients, 67 (29%), 122 (53%), and 40 (18%) were confirmed as SMF, overt PMF, and pre-PMF, respectively. The JAK2 V617F mutation was differentially distributed in SMF and PMF, contradictory to CALR and MPL mutations. Regarding nondriver mutations, the occurrence of ASXL1 mutations differed between PMF and SMF or pre-PMF. The three-year overall survival was 91.5%, 85.3%, and 94.8% in SMF, overt PMF, and pre-PMF groups. Various scoring systems could discriminate the overall survival in PMF but not in SMF and pre-PMF. Still, clinical features including anemia and thrombocytopenia were poor prognostic factors throughout the myelofibrosis, whereas mutations contributed differently. Molecular grouping by wild-type SF3B1 and SRSF2/RUNX1/U2AF1/ASXL1/TP53 mutations showed inferior progression-free survival (PFS) in PMF, SMF, and pre-PMF. We determined the clinical and genetic features related to poor prognosis in myelofibrosis.

Для цитирования: Kim Tong-Yoon, Kwag Daehun, Lee Jong-Hyuk, Lee Joonyeop, Min Gi-June, Park Sung-Soo, Park Silvia, Jeon Young-Woo, Yoon Jae-Ho, Shin Seung-Hawn, Yahng Seung-Ah, Cho Byung-Sik, Eom Ki-Seong, Kim Yoo-Jin, Lee Seok, Kim Hee-Je, Min Chang-Ki, Cho Seok-Goo, Lee Jong-Wook, Lee Jong-Mi, Kim Myungshin, Lee Sung-Eun. Clinical Features, Gene Alterations, and Outcomes in Prefibrotic and Overt Primary and Secondary Myelofibrotic Patients.. Cancers. 2022. DOI: 10.3390/cancers14184485.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.